Polycystic ovary syndrome and metabolic syndrome.
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder, where the main clinical features include menstrual irregularities, sub-fertility, hyperandrogenism, and hirsutism. The prevalence of PCOS depends on ethnicity, environmental and genetic factors, as well as the criteria used to define it. On the other hand, metabolic syndrome is a constellation of metabolic disorders which include mainly abdominal obesity, insulin resistance, impaired glucose metabolism, hypertension and dyslipidaemia. These associated disorders directly increase the risk of Type 2 diabetes mellitus (DMT2), coronary heart disease (CHD), cardiovascular diseases (CVD) and endometrial cancer. Many patients with PCOS have features of metabolic syndrome such as visceral obesity, hyperinsulinaemia and insulin resistance. These place patients with PCOS under high risk of developing cardiovascular disease (CVD), Type 2 diabetes (DMT2) and gynecological cancer, in particular, endometrial cancer. Metabolic syndrome is also increased in infertile women with PCOS. The aim of this review is to provide clear and up to date information about PCOS and its relationship with metabolic syndrome, and the possible interaction between different metabolic disorders.
Aus Tariq
AT
Ali
D002318:Cardiovascular Diseases; D003924:Diabetes Mellitus, Type 2; D005260:Female; D005833:Genital Neoplasms, Female; D006801:Humans; D017588:Hyperandrogenism; D007246:Infertility; D007247:Infertility, Female; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000453:epidemiology*; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000453:epidemiology; D012307:Risk Factors
hypertension.; insulin resistance; metabolic syndrome; polycystic ovary syndrome